Expression of p16(INK4) and retinoblastoma protein Rb in vulvar lesions of Chinese women

Gynecologic Oncology

Volumn 68, Issue 2, 1998, Pages 156-161

  Chan, May K M ^a   Cheung, T H ^a   Chung, T K H ^a   Bao, S Y ^b   Zhao, C L ^b   Nobori, T ^c   Wong, Y F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CHINA; CONDYLOMA; FEMALE; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VULVA CARCINOMA; CHEMISTRY; CONDYLOMA ACUMINATUM; ETHNOLOGY; GENETICS; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; METABOLISM; VULVA; VULVA DISEASE; VULVA TUMOR;

CARCINOMA, SQUAMOUS CELL; CHINA; CONDYLOMATA ACUMINATA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RETINOBLASTOMA PROTEIN; SEVERITY OF ILLNESS INDEX; VULVA; VULVAR DISEASES; VULVAR NEOPLASMS;

EID: 0031987341     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4914     Document Type: Article

References (30)

1. Kamb A, Gruis N A, Weaver F J, Liu Q, Harshman K, Tavtigian S V, Stockert E, Day R S III, Johnson B E, Skolnick M H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
2. Serrano M, Hannon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (London). 366:1993;704-707.
3. Nobori T, Miura K, Wu D J, Lois A, Takabayashi K, Carson D A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London). 368:1994;753-756.
4. Lo K W, Huang D P, Lau K M. p16 gene alteration in nasopharyngeal carcinoma. Cancer Res. 55:1995;2039-2043.
5. INK4INK4B. Cancer Res. 55:1995;1436-1440.
6. INK4INK4B. Cancer Res. 55:1995;2756-2760.
7. Igaki H, Sasaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, Terada M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res. 55:1995;3421-3423.
8. Xiao S, Li D, Corson J M, Vijg J, Fletcher J A. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res. 55:1995;2968-2971.
9. Friend S H, Bernards R, Rogelj S, Weinberg R A, Rapaport J M, Albert D M, Dryja T P. A human DNA segment with properties of the gene that predispose to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
10. Harbour J W, Lai S L, Whang-Peng J, Gazdar A F, Minna J D, Kaye F J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 241:1988;353-357.
11. Horowitz J M, Yandell D W, Park S H, Canning S, Whyte P, Bechkovich K, Harlow E, Weinberg R A, Dryja T P. Point mutation inactivation of the retinoblastoma antioncogene. Science. 243:1989;937-940.
12. Marx J. How the retinoblastoma gene may inhibit cell growth. Science. 252:1991;1492.
13. Hiebert S W, Chellappan S P, Horowitz J M, Nevins J R. The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:1992;177-185.
14. INK4. Cancer Res. 55:1995;4833-4836.
15. Lukas J, Parry D, Aagaard L, Mann D J, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastoma-protein-dependant cell-cycle inhibition by the tumor suppressor p16. Nature. 375:1995;503-506.
16. INK4. Cancer Res. 55:1995;505-509.
17. INK4. Cancer Res. 55:1995;1941-1945.
18. Geradts J, Hu S X, Lincoln C E, Benedict W F, Xu H J. Aberrant Rb gene expression in routinely processed, archival tumor tissues determined by three different anti-Rb antibodies. Int J Cancer. 58:1994;161-167.
19. Reed J A, Loganzo F, Shea C R, Walker G J, Flores J F, Glendening J M, Bogdany J K, Shiel M J, Haluska F G, Fountain J W, Albino A P. Loss of expression of the p16/ Cyclin-dependant kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 55:1995;2713-2718.
20. INK4. Cancer Res. 55:1995;6006-6011.
21. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res. 55:1995;493-497.
22. Li Y, Nichols M A, Shay J W, Xiong Y. Transcriptional repression of the D-type cyclin-dependant kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54:1994;6078-6082.
23. INK4. Oncogene. 9:1994;3375-3378.
24. Sawan A, Randall B, Angus B, Wright C, Henry J A, Ostrowski J, Hennessy C, Lennard T WJ, Corbett I, Horne H W. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J Pathol. 168:1992;23-28.
25. Lipponen P, Eskelinen M, Syrjanen K. Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer. 71:1995;863-867.
26. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shiman T, Shiozaki H, Monden M. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer. 71:1995;1231-1236.
27. Quesnel B, Fenaux P, Philippe N, Bonneterre J, Preudhomme C, Peyrat J P. Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer. 72:1995;351-353.
28. INK4. Cancer Res. 54:1994;5816-5820.
29. 01. Oncogene. 6:1991;1139-1146.
30. Gruis N A, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C, Kamb A. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol. 146:1995;1199-1206.